3D Global Biotech (ROCO:6808) EV-to-EBITDA : -379.65 (As of Dec. 14, 2024)

3D Global Biotech EV-to-EBITDA Chart

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial								-	-22.99	-	-26.48	-

Competitive Comparison of 3D Global Biotech's EV-to-EBITDA

For the Biotechnology subindustry, 3D Global Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Global Biotech's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's EV-to-EBITDA falls into.

3D Global Biotech EV-to-EBITDA Calculation

3D Global Biotech's EV-to-EBITDA for today is calculated as:

3D Global Biotech's current Enterprise Value is NT$2,933.91 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 3D Global Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-7.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Global Biotech  (ROCO:6808) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

3D Global Biotech's PE Ratio (TTM) for today is calculated as:

3D Global Biotech's share price for today is NT$42.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 3D Global Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.514.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

3D Global Biotech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech Business Description